257 related articles for article (PubMed ID: 14976040)
21. Human leukocyte antigen class II expression is a good prognostic factor in adult T-cell leukemia/lymphoma.
Takeuchi M; Miyoshi H; Asano N; Yoshida N; Yamada K; Yanagida E; Moritsubo M; Nakata M; Umeno T; Suzuki T; Komaki S; Muta H; Furuta T; Seto M; Ohshima K
Haematologica; 2019 Aug; 104(8):1626-1632. PubMed ID: 30630986
[TBL] [Abstract][Full Text] [Related]
22. Low GILT Expression is Associated with Poor Patient Survival in Diffuse Large B-Cell Lymphoma.
Phipps-Yonas H; Cui H; Sebastiao N; Brunhoeber PS; Haddock E; Deymier MJ; Klapper W; Lybarger L; Roe DJ; Hastings KT
Front Immunol; 2013; 4():425. PubMed ID: 24409177
[TBL] [Abstract][Full Text] [Related]
23. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
List AF; Spier CM; Miller TP; Grogan TM
Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
[TBL] [Abstract][Full Text] [Related]
24. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
[TBL] [Abstract][Full Text] [Related]
25. Prediction of Outcome in Diffuse Large Cell Lymphoma by the Major Histocompatibility Complex Class II (HLA-DR, DP, DQ) and Class I (HLA-A, B, C) Phenotype.
Rybski JA; Spier CM; Miller TP; Lippman SM; McGee DL; Grogan TM
Leuk Lymphoma; 1991; 6(1):31-8. PubMed ID: 27457573
[TBL] [Abstract][Full Text] [Related]
26. X box-like sequences in the MHC class II region maintain regulatory function.
Gomez JA; Majumder P; Nagarajan UM; Boss JM
J Immunol; 2005 Jul; 175(2):1030-40. PubMed ID: 16002703
[TBL] [Abstract][Full Text] [Related]
27. Class II major histocompatibility complex expression and cell size independently predict survival in canine B-cell lymphoma.
Rao S; Lana S; Eickhoff J; Marcus E; Avery PR; Morley PS; Avery AC
J Vet Intern Med; 2011; 25(5):1097-105. PubMed ID: 21781170
[TBL] [Abstract][Full Text] [Related]
28. Retinoblastoma protein expression facilitates chromatin remodeling at the HLA-DRA promoter.
Osborne A; Tschickardt M; Blanck G
Nucleic Acids Res; 1997 Dec; 25(24):5095-102. PubMed ID: 9396821
[TBL] [Abstract][Full Text] [Related]
29. Clinical and prognostic significance of aberrant T-cell marker expression in 225 cases of de novo diffuse large B-cell lymphoma and 276 cases of other B-cell lymphomas.
Tsuyama N; Ennishi D; Yokoyama M; Baba S; Asaka R; Mishima Y; Terui Y; Hatake K; Takeuchi K
Oncotarget; 2017 May; 8(20):33487-33500. PubMed ID: 28380441
[TBL] [Abstract][Full Text] [Related]
30. Immunophenotype as prognostic factor for diffuse large B-cell lymphoma in patients undergoing clinical risk-adapted therapy.
Veelken H; Vik Dannheim S; Schulte Moenting J; Martens UM; Finke J; Schmitt-Graeff A
Ann Oncol; 2007 May; 18(5):931-9. PubMed ID: 17395602
[TBL] [Abstract][Full Text] [Related]
31. Oct-1 DNA binding activity unresponsive to retinoblastoma protein expression prevents MHC class II induction in a non-small cell lung carcinoma cell line.
Osborne AR; Zhang H; Blanck G
Mol Immunol; 2006 Feb; 43(6):710-6. PubMed ID: 16360016
[TBL] [Abstract][Full Text] [Related]
32. Significance of the expression of major histocompatibility complex class II antigen, HLA-DR and -DQ, with recurrence of papillary thyroid cancer.
Jo YS; Lee JC; Li S; Choi YS; Bai YS; Kim YJ; Lee IS; Rha SY; Ro HK; Kim JM; Shong M
Int J Cancer; 2008 Feb; 122(4):785-90. PubMed ID: 17957790
[TBL] [Abstract][Full Text] [Related]
33. T-cell repertoire in a strain of transgenic C57BL/6 mice with the HLA-DRA gene on the X-chromosome.
Fukui Y; Esaki Y; Kimura A; Hirokawa K; Nishimura Y; Sasazuki T
Immunogenetics; 1993; 37(3):204-11. PubMed ID: 8420827
[TBL] [Abstract][Full Text] [Related]
34. Two B cell factors bind the HLA-DRA X box region and recognize different subsets of HLA class II promoters.
Hasegawa SL; Boss JM
Nucleic Acids Res; 1991 Nov; 19(22):6269-76. PubMed ID: 1956787
[TBL] [Abstract][Full Text] [Related]
35. Regulation of major histocompatibility (MHC) class II human leukocyte antigen-DR alpha gene expression in thyrocytes by single strand binding protein-1, a transcription factor that also regulates thyrotropin receptor and MHC class I gene expression.
Balducci-Silano PL; Suzuki K; Ohta M; Saito J; Ohmori M; Montani V; Napolitano G; Shong M; Taniguchi SI; Pietrarelli M; Lavaroni S; Mori A; Singer DS; Kohn LD
Endocrinology; 1998 May; 139(5):2300-13. PubMed ID: 9564838
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of G1B and G3A IFN gamma mutants reveals that defects in CIITA or RFX result in defective class II MHC and Ii gene induction.
Chin KC; Mao C; Skinner C; Riley JL; Wright KL; Moreno CS; Stark GR; Boss JM; Ting JP
Immunity; 1994 Nov; 1(8):687-97. PubMed ID: 7600294
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of major histocompatibility complex class II gene expression and demonstration of antigen-specific T cell response indicate a new phenotype in class II-deficient patients.
Hauber I; Gulle H; Wolf HM; Maris M; Eggenbauer H; Eibl MM
J Exp Med; 1995 Apr; 181(4):1411-23. PubMed ID: 7699327
[TBL] [Abstract][Full Text] [Related]
38. In vivo footprint analysis of the HLA-DRA gene promoter: cell-specific interaction at the octamer site and up-regulation of X box binding by interferon gamma.
Wright KL; Ting JP
Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7601-5. PubMed ID: 1502171
[TBL] [Abstract][Full Text] [Related]
39. Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression.
Abdulkadir SA; Krishna S; Thanos D; Maniatis T; Strominger JL; Ono SJ
J Exp Med; 1995 Aug; 182(2):487-500. PubMed ID: 7629508
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor alpha response elements in the HLA-DRA promoter: identification of a tumor necrosis factor alpha-induced DNA-protein complex in astrocytes.
Panek RB; Moses H; Ting JP; Benveniste EN
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11518-22. PubMed ID: 1454841
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
